zoledronic acid has been researched along with phosphorus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambler, G; Cowell, CT; Högler, W; Little, D; McQuade, M; Yap, F | 1 |
| Alon, US; Freundlich, M | 1 |
| Filella, X; Florez, H; Guañabens, N; Mandelikova, S; Monegal, A; Peris, P | 1 |
3 other study(ies) available for zoledronic acid and phosphorus
| Article | Year |
|---|---|
Short-term safety assessment in the use of intravenous zoledronic acid in children.
Topics: Adolescent; Bone Resorption; Calcium; Child; Child, Preschool; Creatinine; Diphosphonates; Female; Fever; Follow-Up Studies; Humans; Imidazoles; Infusions, Intravenous; Male; Nausea; Pain; Phosphorus; Retrospective Studies; Time Factors; Urea; Vomiting; Zoledronic Acid | 2004 |
Bisphosphonates in children with hypercalciuria and reduced bone mineral density.
Topics: Adolescent; Alendronate; Bone Density; Bone Density Conservation Agents; Bone Resorption; Calcium; Child; Creatinine; Diphosphonates; Female; Humans; Hypercalciuria; Imidazoles; Male; Phosphorus; Retrospective Studies; Zoledronic Acid | 2008 |
Clinical significance of increased serum levels of FGF-23 in fibrous dysplasia.
Topics: Adult; Aged; Alendronate; Biomarkers; Bone Density Conservation Agents; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibrous Dysplasia of Bone; Humans; Male; Middle Aged; Osteomalacia; Pamidronate; Phosphorus; Reference Values; Young Adult; Zoledronic Acid | 2018 |